Briacell Therapeutics Corp (BCT.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Operating Expenses | 27,205 | 33,330 | 23,272 | 15,286 | 6,970 |
| Operating Income | -27,205 | -33,330 | -23,272 | -15,286 | -6,970 |
| Interest Expense | 37 | N/A | 0 | 1 | 46 |
| Other Income | 686 | 28,399 | 2,970 | -11,552 | 6,588 |
| Pre-tax Income | -26,556 | -4,932 | -20,302 | -26,839 | -428 |
| Net Income Continuous | -26,556 | -4,932 | -20,302 | -26,839 | -428 |
| Minority Interests | 244 | 140 | N/A | N/A | N/A |
| Net Income | $-26,312 | $-4,791 | $-20,302 | $-26,839 | $-428 |
| EPS Basic Total Ops | -62.19 | -43.50 | -195.00 | -259.50 | -13.50 |
| EPS Basic Continuous Ops | -62.19 | -43.50 | -195.00 | -259.50 | -13.50 |
| EPS Diluted Total Ops | -62.19 | -43.50 | -195.00 | -259.50 | -13.50 |
| EPS Diluted Continuous Ops | -62.19 | -43.50 | -195.00 | -259.50 | -13.50 |
| EBITDA(a) | $-26,413 | $-33,246 | $-20,287 | $-26,823 | $-367 |